COVID-19 Outbreak-Global Precision Medicine Software Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
SKU ID : Maia-15748120 | Publishing Date : 04-Jun-2020 | No. of pages : 113
The Precision Medicine Software market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Precision Medicine Software industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Precision Medicine Software market can be split based on product types, major applications, and important countries as follows:
Key players in the global Precision Medicine Software market covered in Chapter 12:
Pfizer, Inc., Merck & Co., Inc.(US)
Translational Software, Inc. (US)
N-of-One, Inc. (US)
Qiagen(Germany)
Sunquest Information Systems Inc. (US)
Flatiron Health, Inc. (US)
SOPHiA GENETICS SA (Switzerland)
LifeOmic Health, LLC (US)
GlaxoSmithKline plc(UK)
AstraZeneca plc(US)
Sanofi S.A.(France)
Allscripts(US)
Tempus Labs, Inc. (US)
PierianDx, Inc. (US)
Syapse, Inc. (US)
IBM Watson Group (US)
Koninklijke Philips N.V. (Netherlands)
Foundation Medicine, Inc. (US)
Human Longevity, Inc. (US)
Roper Technologies(US)
NantHealth, Inc. (US)
2bPrecise LLC (Israel)
Abbott Laboratories(US)
Gene42, Inc. (Canada)
Fabric Genomics (US)
In Chapter 4 and 14.1, on the basis of types, the Precision Medicine Software market from 2015 to 2025 is primarily split into:
Cloud-based
On-premise
In Chapter 5 and 14.2, on the basis of applications, the Precision Medicine Software market from 2015 to 2025 covers:
Healthcare providers
Research centers & Government institutes
Pharmaceutical & Biotechnology companies
Other end users
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years:
2015-2019Base Year:
2019Estimated Year:
2020Forecast Period:
2020-2025Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region